• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC ARROW CVC SET: 3-LUMEN 12 FR X 16 CM; CATHETER INTRAVASCULAR THERAPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC ARROW CVC SET: 3-LUMEN 12 FR X 16 CM; CATHETER INTRAVASCULAR THERAPE Back to Search Results
Model Number IPN919469
Medical Device Problem Code Material Separation (1562)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 09/24/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Qn(b)(4).
 
Event or Problem Description
It was reported that " user found that the arterial line of the catheter had broken near the insertion hub." additional information received states "the issue was identified too late, resulting in the patient experiencing blood loss that required the administration of one unit of blood." the patient was in critical condition prior to using the device.It was reported "the patient passed away due to their overall clinical condition, unrelated to the incident".
 
Additional Manufacturer Narrative
(b)(4).The actual device was not returned; however, the customer provided two photos for analysis.The photos show the medial extension line with a hole in the connection adjacent to the juncture hub; however, a complete visual inspection to determine the cause of the damage could not be performed as no sample was returned for analysis.A device history record review was performed and no relevant findings were identified.The instructions for use (ifu) provided with this kit warns the user, "do not secure, staple and/or suture directly to outside diameter of catheter body or extension lines to reduce risk of cutting or damaging the catheter or impeding catheter flow.Secure only at indicated stabilization locations." without the device to evaluate, the probable cause could not be determined from the available information.Teleflex will continue to monitor and trend for reports of this nature.
 
Event or Problem Description
It was reported that " user found that the arterial line of the catheter had broken near the insertion hub." additional information received states "the issue was identified too late, resulting in the patient experiencing blood loss that required the administration of one unit of blood." the patient was in critical condition prior to using the device.It was reported "the patient passed away due to their overall clinical condition, unrelated to the incident".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROW CVC SET: 3-LUMEN 12 FR X 16 CM
Common Device Name
CATHETER INTRAVASCULAR THERAPE
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL CR, A.S.
jamska 2359/47
zdar nad sazavou 591 0 1
EZ   591 01
Manufacturer Contact
katharine tarpley
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key23617461
Report Number3006425876-2025-01094
Device Sequence Number10072698
Product Code FOZ
UDI-Device Identifier10801902219203
UDI-Public(01)10801902219203(11)240820(17)290731(10)71F24H0598(21)
Combination Product (Y/N)N
Initial Reporter CountryPO
PMA/510(K) Number
K970864
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 10/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberIPN919469
Device Catalogue NumberCV-12123-F
Device Lot Number71F24H0598
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/30/2025
Supplement Date Received by Manufacturer12/15/2025
Initial Report FDA Received Date11/21/2025
Supplement Report FDA Received Date12/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/20/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NOT REPORTED.; NOT REPORTED.
Patient SexUnknown
-
-